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We would like to commend the authors Weber et al. [1] for their study assessing BCVI and stroke in such a large series of patients. However, we have a few questions and concerns about the study.
Computed tomographic angiography (CTA) was applied for primary blunt cerebrovascular injury (BCVI) screening, but the authors do not specify whether all 76,480 individuals received a CTA study. If not, what criteria were used to screen patients with CTA? The conclusions drawn about the utility of screening criteria in predicting BCVI would be valid if all patients were screened. Retrospective analysis of risk factors may not be an accurate method if all patients were not consistently screened.
The literature is very heterogeneous about the sensitivity and specificity of CTA, and different studies advocate conventional angiography in CTA-negative and CTApositive patients, respectively [2, 3] . We would request the authors to comment on the use of conventional angiography in their dataset. The reported incidence of BCVI in the literature is reflective of not only the screening criteria used, but also the sensitivity of the imaging used to screen patients.
It would also be helpful to know from the authors the use of medical prophylaxis in both screened and unscreened patients. 30/58 strokes in this study happened despite prophylaxis, and 10/58 happened before start of therapy. The utility of screening criteria and CTAs has to be seen in the context of use of subsequent treatment and thereby prevention of stroke.
Greater awareness of BCVI, the grading of injury and imaging pitfalls would help improve noninvasive imaging diagnosis [4] . Optimized, selective CTA in high-risk populations may be the most cost-effective strategy for BCVI detection [5] .
